GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sunrest Lifescience Ltd (NSE:SUNREST) » Definitions » ROE %

Sunrest Lifescience (NSE:SUNREST) ROE % : 2.61% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sunrest Lifescience ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Sunrest Lifescience's annualized net income for the quarter that ended in Mar. 2024 was ₹2.3 Mil. Sunrest Lifescience's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was ₹86.5 Mil. Therefore, Sunrest Lifescience's annualized ROE % for the quarter that ended in Mar. 2024 was 2.61%.

The historical rank and industry rank for Sunrest Lifescience's ROE % or its related term are showing as below:

NSE:SUNREST' s ROE % Range Over the Past 10 Years
Min: 2.61   Med: 78.01   Max: 113.7
Current: 2.61

During the past 5 years, Sunrest Lifescience's highest ROE % was 113.70%. The lowest was 2.61%. And the median was 78.01%.

NSE:SUNREST's ROE % is ranked worse than
56.23% of 626 companies
in the Healthcare Providers & Services industry
Industry Median: 4.715 vs NSE:SUNREST: 2.61

Sunrest Lifescience ROE % Historical Data

The historical data trend for Sunrest Lifescience's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunrest Lifescience ROE % Chart

Sunrest Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
ROE %
28.44 78.01 113.70 97.63 2.61

Sunrest Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Mar24
ROE % 28.44 78.01 113.70 97.63 2.61

Competitive Comparison of Sunrest Lifescience's ROE %

For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunrest Lifescience's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's ROE % distribution charts can be found below:

* The bar in red indicates where Sunrest Lifescience's ROE % falls into.



Sunrest Lifescience ROE % Calculation

Sunrest Lifescience's annualized ROE % for the fiscal year that ended in Mar. 2024 is calculated as

ROE %=Net Income (A: Mar. 2024 )/( (Total Stockholders Equity (A: Mar. 2023 )+Total Stockholders Equity (A: Mar. 2024 ))/ count )
=2.257/( (31.136+141.854)/ 2 )
=2.257/86.495
=2.61 %

Sunrest Lifescience's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Mar. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=2.257/( (31.136+141.854)/ 2 )
=2.257/86.495
=2.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.


Sunrest Lifescience  (NSE:SUNREST) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=2.257/86.495
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(2.257 / 294.716)*(294.716 / 209.3375)*(209.3375 / 86.495)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.77 %*1.4079*2.4202
=ROA %*Equity Multiplier
=1.08 %*2.4202
=2.61 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=2.257/86.495
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (2.257 / 5.927) * (5.927 / 8.101) * (8.101 / 294.716) * (294.716 / 209.3375) * (209.3375 / 86.495)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.3808 * 0.7316 * 2.75 % * 1.4079 * 2.4202
=2.61 %

Note: The net income data used here is one times the annual (Mar. 2024) net income data. The Revenue data used here is one times the annual (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Sunrest Lifescience ROE % Related Terms

Thank you for viewing the detailed overview of Sunrest Lifescience's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunrest Lifescience Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Vastral Road, FF-41, Ajay Tenament-6 Near Canal, Near Ritanagar Bus Stand, Ahmedabad, GJ, IND, 382415
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products on a wholesale and retail basis. It deals in Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Its product portfolio comprises Analgesic & Anti Pyretic3030, Antacid Anti Emetics1414, Anti Biotics1717, Anti Cough & Cold4343, Anti Fungal2929, Anti Spasmodic & Enzyme99, Creams & Ointments44, Eye, Ear Drops & Nasal Spray88, General Products2828, Glucose & Energy Drink88, Hair Care77, Lady Care55, Multi Vitamins & Haemantinics3030, Oral Care55, Skin Care2222, and Vigor and Vitality.

Sunrest Lifescience Headlines

No Headlines